Skip to search.
 FTSE 100 Up 1.68%

More On FURX

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

(FURX)

-NasdaqGS
0.00 0.00(0.00%) N/A
Add to Portfolio
Prev Close:N/A
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:115.00
Beta:1.63
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:103.08 - 106.77
Volume:0
Avg Vol (3m):N/A
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-5.04
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in .

Comparison

Symbol% ChgMkt Cap
FURX 0.00%N/A
AMRIUp 0.86%659.72m

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Furiex Pharmaceuticals, Inc. operates as a drug development company that is involved in compound development and collaboration activities primarily in the United States. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback